Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.globenewswire.com//news-release/2024/01/02/2802574/0/en/ExCellThera-to-Conduct-Investor-Meetings-During-the-J-P-Morgan-42nd-Annual-Healthcare-Conference-and-to-Participate-in-Upcoming-Investor-Conferences.html
https://www.globenewswire.com//news-release/2023/12/12/2794600/0/en/ExCellThera-Announces-Positive-Phase-2-Study-Results-from-UM171-Cell-Therapy-in-Patients-with-High-risk-Leukemias-and-Myelodysplasias-at-American-Society-of-Hematology-ASH-2023-Ann.html
https://www.globenewswire.com//news-release/2023/11/03/2773160/0/en/ExCellThera-announces-new-UM171-data-to-be-presented-at-ASH-2023.html
https://www.globenewswire.com//news-release/2022/12/12/2571866/0/en/UM171-cell-therapy-demonstrates-improved-outcomes-compared-to-cord-and-matched-unrelated-donor-peripheral-blood-transplants-in-real-world-setting.html
https://www.globenewswire.com/news-release/2022/11/15/2556207/0/en/ExCellThera-announces-completion-of-Phase-2-clinical-trials-for-UM171-expanded-cell-therapy-in-high-risk-blood-cancers.html
https://www.globenewswire.com/news-release/2022/11/08/2550973/0/en/ExCellThera-announces-100th-patient-treated-with-UM171-expanded-cell-therapy.html
https://www.globenewswire.com/news-release/2022/11/04/2548863/0/en/ExCellThera-announces-oral-presentation-of-new-data-on-UM171-expanded-cell-therapy-at-the-ASH-Annual-Meeting.html
https://www.globenewswire.com/news-release/2022/06/17/2464666/0/en/ExCellThera-announces-submission-of-Drug-Master-File-for-UM171.html
https://www.globenewswire.com/news-release/2022/04/13/2421896/0/en/ExCellThera-announces-new-publication-showing-its-ECT-001-cell-therapy-improves-transplant-access-for-all-patients.html
https://www.globenewswire.com/news-release/2022/03/15/2403393/0/en/ExCellThera-announces-new-data-to-be-presented-at-the-EBMT-2022-annual-meeting.html